Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.
about
Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and ToxicologyFCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.Intrauterine growth restriction and placental angiogenesisVascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.What role for angiogenesis in childhood acute lymphoblastic leukaemia?VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironmentDoes adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?Critical signal transduction pathways in CLL.Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.Clinical trials with anti-angiogenic agents in hematological malignancies.The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.Regulation of CLL survival by hypoxia-inducible factor and its target genes.Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3.Angiogenesis in myeloproliferative neoplasms, new markers and future directions.PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions.Circulating endothelial cells in chronic lymphocytic leukemia: more evidence of disturbed angiogenesis.SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers.
P2860
Q26765484-54970190-F736-404D-8A72-2B17FC0651F9Q33416596-7F3F0AC5-86E0-4FCA-A027-4CF6E0828D1EQ33634642-AD0256C8-CAE6-4DB8-8014-46E3F6A40C47Q33833123-6FAED125-9A07-47B2-9C01-38FB3DF0F96BQ33874179-5233039E-70EF-432D-B2A6-7A8B4ABD04FEQ35550914-281AD0D6-542A-463F-A6E9-BE3B677EB740Q36651022-B6DF05FF-846F-48DF-98D1-86AD53B2C704Q37097867-2E707029-5918-48CC-B6B9-9E5B8E3DC67BQ37424750-9E8416AB-36C2-4D01-BD80-2F17BC188F9EQ37571068-EE46BD15-4A56-4F33-8FC2-C94D16BF31AEQ37591356-1F3F076B-6933-4578-A387-4201F8EBB083Q37766940-53045583-D879-41CC-BB49-BF9A12191BC8Q37884379-6CFA5A08-148A-42F8-BF60-896C0718FDE1Q38030217-33D0685D-E943-4ADA-BEF7-3B8F941890CAQ39511827-702C15BB-AF1B-4075-A6F1-D71D80C80954Q42622713-2FCFF5E8-5770-41F4-92B4-03E5216B0131Q51219604-424E191A-B4AB-466A-9644-5329C0BE1BB3Q53420162-4051B04F-F977-4206-8F5E-6ED7842D67C7Q53632145-302F29E6-796F-4EE8-9297-CFB8ED214CA0
P2860
Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@ast
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@en
type
label
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@ast
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@en
prefLabel
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@ast
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@en
P2093
P2860
P356
P1433
P1476
Dysregulated angiogenesis in B ...... and flow cytometric evidence.
@en
P2093
Charles L Goolsby
Gordon W Dewald
John L Frater
LoAnn C Peterson
Neil E Kay
Susan E Crawford
P2860
P2888
P356
10.1186/1746-1596-3-16
P577
2008-04-18T00:00:00Z
P5875
P6179
1017261472